Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Disetronic plans to go public in summer

This article was originally published in Clinica

Executive Summary

Swiss drug delivery manufacturer Disetronic intends to float on the Zurich stock exchange this summer. Around 30% of the company will be offered to the public, with some 20% sold by two Swiss banks and the rest issued as new shares by Disetronic. The company will use the proceeds to extend the sterile disposable products business and accelerate expansion into new international markets. After the float, Disetronic will continue to be controlled by majority shareholder and CEO Willy Michel.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087442

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel